CORMUNE Trademark

Trademark Overview


On Friday, April 10, 2020, a trademark application was filed for CORMUNE with the United States Patent and Trademark Office. The USPTO has given the CORMUNE trademark a serial number of 88867322. The federal status of this trademark filing is REGISTERED as of Tuesday, March 16, 2021. This trademark is owned by CHANDLER BIOPHARMACEUTICAL INC.. The CORMUNE trademark is filed in the Pharmaceutical Products category with the following description:

Anti-cancer preparations; Anti-diabetic pharmaceuticals; Anti-diabetic preparations; Anti-inflammatories; Anti-inflammatory preparations; Antidiabetic preparations; Antihistamines; Antivirals; Dietary supplements; Dietary supplements for pets; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Food for babies; Food for infants; Food supplements; Medical dressings; Medical plasters; Medicated dentifrices; Medicated shampoo; Medic...
cormune

General Information


Serial Number88867322
Word MarkCORMUNE
Filing DateFriday, April 10, 2020
Status700 - REGISTERED
Status DateTuesday, March 16, 2021
Registration Number6296869
Registration DateTuesday, March 16, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 11, 2020

Trademark Statements


Goods and ServicesAnti-cancer preparations; Anti-diabetic pharmaceuticals; Anti-diabetic preparations; Anti-inflammatories; Anti-inflammatory preparations; Antidiabetic preparations; Antihistamines; Antivirals; Dietary supplements; Dietary supplements for pets; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Food for babies; Food for infants; Food supplements; Medical dressings; Medical plasters; Medicated dentifrices; Medicated shampoo; Medicated shampoos; Medicated soap; Medicated soaps; Medicated sweets; Nutritional and dietary supplements formed and packaged as bars; Nutritional supplement energy bars; Nutritional supplement for eliminating toxins from the body; Nutritional supplement meal replacement bars for boosting energy; Nutritional supplement shakes; Nutritional supplements; Nutritional supplements in capsule form for dogs; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Nutritional supplements in the nature of nutritionally fortified soft chews; Nutritionally fortified beverages for medical purposes; Nutritive substances for micro-organisms for medical use; Nutritive substances for microorganism cultures; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, antidepressants; Prebiotic supplements; Probiotic animal feed; Probiotic preparations for medical use; Probiotic supplements; Vaccine adjuvants; Vaccine preparations; Vaccine stabilizers; Vaccines; Vaccines against flu; Vaccines against pneumococcal infections; Vaccines for cattle; Vaccines for horses; Adjuvants for use with vaccines; Amino acids for nutritional purposes; Animal feed additive for use as a nutritional supplement for medical purposes; Animal feed additives for use as nutritional supplements; Baby food; Candy, medicated; Central nervous system stimulants; Cultures of microorganisms for medical or veterinary use; Dietary and nutritional supplements; Dietary and nutritional supplements for endurance sports; Dietary supplement for eliminating toxins from the intestinal tract; Fungal extracts sold as a component ingredient of nutritional supplements and vitamins; Gastro-intestinal treatment preparations; Hair growth stimulants; Human vaccine preparations; Ketogenic dietary and nutritional supplements; Ketogenic dietary and nutritional supplements used for weight loss; Liquid nutritional supplement; Medicated mouth care and treatment preparations; Medicated mouth washes; Medicated anti-cavity mouth rinses; Medicines for intestinal disorders; Mineral nutritional supplements; Natural remedy preparations for the treatment of gastro-intestinal conditions, hormonal and chemical imbalances, and sleep disorders; Non-medicated additives for animal feed for use as nutritional supplements; Nutritional supplement for eliminating toxins from the intestinal tract; Nutritional supplements, namely, probiotic compositions; Nutritive substances for microorganisms for medical purposes; Oral vaccine preparations; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of hormonal disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Powdered nutritional supplement concentrate; Powdered nutritional supplement drink mix; Respiratory stimulants; Therapeutic vaccines; Vegan protein for use as a nutritional supplement in ready-to-drink beverages; Veterinary vaccine for horses; Veterinary vaccines; Veterinary preparations for treatment of intestinal bacteria

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, April 19, 2020
Primary Code005
First Use Anywhere DateWednesday, January 1, 2020
First Use In Commerce DateFriday, June 26, 2020

Trademark Owner History


Party NameCHANDLER BIOPHARMACEUTICAL INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressELKHART, IN 46516

Party NameCHANDLER BIOPHARMACEUTICAL INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressELKHART, IN 46516

Party NameCHANDLER BIOPHARMACEUTICAL INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressELKHART, IN 46516

Trademark Events


Event DateEvent Description
Tuesday, March 16, 2021REGISTERED-PRINCIPAL REGISTER
Friday, February 12, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, February 11, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 19, 2021STATEMENT OF USE PROCESSING COMPLETE
Wednesday, December 30, 2020USE AMENDMENT FILED
Tuesday, January 19, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 30, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, October 6, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 11, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 11, 2020PUBLISHED FOR OPPOSITION
Wednesday, July 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 6, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, June 28, 2020ASSIGNED TO EXAMINER
Sunday, April 19, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, April 14, 2020NEW APPLICATION ENTERED IN TRAM